biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Aarcoron Jun 26, 2018 9:48pm

106 Views

Post# 28233973

RE:RE:At an all time low for the share price today

More fretting. The 59 cent gap had to fill, just like it always has every.... single..... time for the last 6 years.

If you're paying attention you know it had to get here. It's a good thing, just like the big block this week. I'm happy about it.

I'm hoping there are lots of sellers at 0.60 tomorrow. I'll be looking to add.

Bullboard Posts

The top 10 Canadian medical stocks